Study the effectiveness and safety of vitamin D as an additional treatment for type 2 diabetic patients using oral anti-diabetics at a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20233995Keywords:
FBS, HbA1c, Type 2 diabetes mellitus, Vitamin D supplementationAbstract
Background: The prevalence of type 2 DM is alarmingly rising on a global scale. Improved treatments for type 2 DM are still needed, in order to slow the disease’s development. A role in the pathophysiology of type 2 DM has been suggested by the correlation between vitamin D insufficiency and several non-skeletal illnesses, including DM. The goal of the study was to determine if vitamin D supplementation may help type 2 DM patients whose glycemic status was uncontrolled even after using oral antidiabetics.
Methods: 60 individuals with type 2 DM and vitamin D insufficiency participated in this 12-week open-label, before-and-after study. For 12 weeks, in addition to oral anti-diabetic medications, these patients also received 60,000 IU of vitamin D3 orally every week. HbA1c, FBS, and 25(OH)D levels parameters were included.
Results: The majority of the patients were from 41-50 years of age group (48.3%) with a male predominance (60%). Most of them were having >1 year of type 2 DM duration (78.3%) with a high family history of type 2 DM (70%). After 12 weeks, there was a substantial (p<0.001*) drop in FBG levels and a significant (p<0.001*) decrease in HbA1c. 25(OH)D levels showed a high rise (p<0.001*). None of the patients had any side effects.
Conclusions: Vitamin D treatment improves glycemic status, which slows the development of type 2 DM and its associated effects. As such, vitamin D supplementation is a safe and promising adjuvant treatment for individuals with type 2 diabetes who are low in vitamin D.
References
Ramachandran A, Das AK, Joshi SR, Yagnik CS, Shah S, Kumar KM. Current status of diabetes in India and need for novel therapeutic agents. JAPI. 2010;58:7-9.
Buse JB, Polonsky KS, Burant CF. Type 2 diabetes mellitus. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 12th Edn. Philadelphia: Saunders; 2011:1371.
Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110-7.
Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94(1):26-34.
Eliades M, Pittas AJ. Vitamin D and type 2 diabetes. Clin Rev Bone Miner Metab. 2009;7:185-98.
Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr. 2013;5(1):8.
von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient- a randomised, placebo-controlled trial. Br J Nutr. 2010;103(4):549-55.
Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, et al. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: An 18-month prospective interventional study. Cardiovasc Diabetol. 2012;11(85):1-7.
Vijay GS, Ghonge S, Vajjala SM, Palal D. Prevalence of vitamin D deficiency in type 2 diabetes mellitus patients: a cross-sectional study. Cureus. 2023;15(5):1-9.
Nasri H, Behradmanesh S, Maghsoudi AR, Ahmadi A, Nasri P, Rafieian-Kopaei M. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Ren Inj Prev. 2014;3:31-4.
Lalitha A, Tripathi MK, Sharma DW, Naveen AP, Chalam KS. Impact of treating vitamin D deficiency on blood sugar levels in patients with type 2 diabetes mellitus and prediabetes. JAPI. 2011;59.
Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with Type 2 diabetes. Diabetol Metab Syndr. 2013;5(1):8.
Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, et al. Effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci. 2012;20:10.
Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: a pilot prospective randomized trial. J Diabetes. 2010;2(1):36-40.
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381(6):520-30.
